314 related articles for article (PubMed ID: 25395898)
1. Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.
Parikh NR; Mandal A; Bhatia D; Siveen KS; Sethi G; Bishayee A
Phytochem Rev; 2014 Dec; 13(4):793-810. PubMed ID: 25395898
[TBL] [Abstract][Full Text] [Related]
2. Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer.
Bishayee A; Ahmed S; Brankov N; Perloff M
Front Biosci (Landmark Ed); 2011 Jan; 16(3):980-96. PubMed ID: 21196213
[TBL] [Abstract][Full Text] [Related]
3. Application of the taraxerane-oleanane rearrangement to the synthesis of seco-oleanane triterpenoids from taraxerone.
Giang PM; Minh Trang V; Son PT; Matsunami K
Nat Prod Res; 2015; 29(1):64-9. PubMed ID: 25219952
[TBL] [Abstract][Full Text] [Related]
4. Triterpenoids for cancer prevention and treatment: current status and future prospects.
Patlolla JM; Rao CV
Curr Pharm Biotechnol; 2012 Jan; 13(1):147-55. PubMed ID: 21466427
[TBL] [Abstract][Full Text] [Related]
5. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
Salvador JAR; Leal AS; Valdeira AS; Gonçalves BMF; Alho DPS; Figueiredo SAC; Silvestre SM; Mendes VIS
Eur J Med Chem; 2017 Dec; 142():95-130. PubMed ID: 28754470
[TBL] [Abstract][Full Text] [Related]
6. Oleanane derivatives for pharmaceutical use: a patent review (2000-2016).
Masullo M; Pizza C; Piacente S
Expert Opin Ther Pat; 2017 Mar; 27(3):237-255. PubMed ID: 27782764
[TBL] [Abstract][Full Text] [Related]
7. Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence.
Shanmugam MK; Dai X; Kumar AP; Tan BK; Sethi G; Bishayee A
Cancer Lett; 2014 May; 346(2):206-16. PubMed ID: 24486850
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of Oleanane and Ursane Triterpenic Acids.
Luchnikova NA; Grishko VV; Ivshina IB
Molecules; 2020 Nov; 25(23):. PubMed ID: 33255782
[TBL] [Abstract][Full Text] [Related]
9. A Review on Structure-Activity Relationships of Glycyrrhetinic Acid Derivatives with Diverse Bioactivities.
Liu Y; Sheng R; Fan J; Guo R
Mini Rev Med Chem; 2022; 22(15):2024-2066. PubMed ID: 35081889
[TBL] [Abstract][Full Text] [Related]
10. Role of Pentacyclic Triterpenoids in Chemoprevention and Anticancer Treatment: An Overview on Targets and Underling Mechanisms.
Ghante MH; Jamkhande PG
J Pharmacopuncture; 2019 Jun; 22(2):55-67. PubMed ID: 31338244
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Tumour-Related Signaling Pathways by Natural Pentacyclic Triterpenoids and their Semisynthetic Derivatives.
Markov AV; Zenkova MA; Logashenko EB
Curr Med Chem; 2017; 24(13):1277-1320. PubMed ID: 28078994
[TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer.
Shanmugam MK; Nguyen AH; Kumar AP; Tan BK; Sethi G
Cancer Lett; 2012 Jul; 320(2):158-70. PubMed ID: 22406826
[TBL] [Abstract][Full Text] [Related]
13. New Applications of Oleanolic Acid and its Derivatives as Cardioprotective Agents: A Review of their Therapeutic Perspectives.
Sun N; Li D; Chen X; Wu P; Lu YJ; Hou N; Chen WH; Wong WL
Curr Pharm Des; 2019; 25(35):3740-3750. PubMed ID: 31692428
[TBL] [Abstract][Full Text] [Related]
14. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
Deeb D; Gao X; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
[TBL] [Abstract][Full Text] [Related]
15. Nanoformulations for Delivery of Pentacyclic Triterpenoids in Anticancer Therapies.
Kaps A; Gwiazdoń P; Chodurek E
Molecules; 2021 Mar; 26(6):. PubMed ID: 33801096
[TBL] [Abstract][Full Text] [Related]
16. Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases.
Ayeleso TB; Matumba MG; Mukwevho E
Molecules; 2017 Nov; 22(11):. PubMed ID: 29137205
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory Oleanane-Type Triterpenoids Produced by
Yu H; Chen Y; Cheng Z; Li H; Bian H; Yang X; Lv J; Liu W; Su L; Sun P
J Agric Food Chem; 2023 Mar; 71(8):3777-3789. PubMed ID: 36802538
[TBL] [Abstract][Full Text] [Related]
18. New nor-oleanane triterpenoids from the fruits of
Li J; Du K; Liu D; Meng D
Nat Prod Res; 2020 Apr; 34(7):915-922. PubMed ID: 30600711
[TBL] [Abstract][Full Text] [Related]
19. Potential anti-inflammation nor-oleanane triterpenoids from the fruits of
Yang W; Chen M; Meng D; Wei P
Nat Prod Res; 2019 Dec; 33(23):3350-3356. PubMed ID: 29882439
[TBL] [Abstract][Full Text] [Related]
20. Spectroscopic analysis on structure-affinity relationship in the interactions of different oleanane-type triterpenoids with bovine serum albumin.
Hou J; Wang Z; Yue Y; Li Q; Shao S
Luminescence; 2015 Sep; 30(6):780-9. PubMed ID: 25428559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
